ENTA logo

Enanta Pharmaceuticals (ENTA) Net Margin

Annual Net Margin

-171.58%
-2.63%-1.56%

September 30, 2024


Summary


Performance

ENTA Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherENTAprofitabilitymetrics:

Quarterly Net Margin

-197.32%
-71.24%-56.50%

September 30, 2024


Summary


Performance

ENTA Quarterly Net Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherENTAprofitabilitymetrics:

Net Margin Formula

Net Margin =  Net Income
Revenue
✕ 100%

ENTA Net Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-1.6%-32.9%
3 y3 years-110.8%-89.1%
5 y5 years-859.2%-89.1%

ENTA Net Margin Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-110.8%at low-81.2%+6.8%
5 y5-year-859.2%at low-871.7%+6.8%
alltimeall time-337.8%at low-324.7%+67.2%

Enanta Pharmaceuticals Net Margin History

DateAnnualQuarterly
Sep 2024
-171.58%(+1.6%)
-197.32%(+56.5%)
Jun 2024
-
-126.08%(-31.0%)
Mar 2024
-
-182.70%(-1.5%)
Dec 2023
-
-185.56%(+25.0%)
Sep 2023
-168.95%(+19.6%)
-148.46%(-28.2%)
Jun 2023
-
-206.78%(-2.3%)
Mar 2023
-
-211.62%(+72.2%)
Dec 2022
-
-122.90%(-5.2%)
Sep 2022
-141.31%(+73.6%)
-129.68%(-20.3%)
Jun 2022
-
-162.74%(-9.3%)
Mar 2022
-
-179.48%(+64.8%)
Dec 2021
-
-108.92%(+4.4%)
Sep 2021
-81.38%(+175.6%)
-104.34%(-6.1%)
Jun 2021
-
-111.10%(+1.5%)
Mar 2021
-
-109.50%(+317.3%)
Dec 2020
-
-26.24%(-78.9%)
Sep 2020
-29.53%(-230.7%)
-124.16%(+62.3%)
Jun 2020
-
-76.48%(+251.8%)
Mar 2020
-
-21.74%(-185.0%)
Dec 2019
-
25.57%(+42.8%)
Sep 2019
22.60%(-35.1%)
17.91%(+12.9%)
Jun 2019
-
15.86%(+51.6%)
Mar 2019
-
10.46%(-71.9%)
Dec 2018
-
37.22%(-8.8%)
Sep 2018
34.82%
40.80%(+15.2%)
Jun 2018
-
35.43%(+24.3%)
DateAnnualQuarterly
Mar 2018
-
28.50%(-7.1%)
Dec 2017
-
30.68%(-36.2%)
Sep 2017
17.23%(-29.8%)
48.08%(-142.9%)
Jun 2017
-
-112.18%(+86.4%)
Mar 2017
-
-60.19%(+25.9%)
Dec 2016
-
-47.81%(+240.8%)
Sep 2016
24.55%(-50.0%)
-14.03%(+82.2%)
Jun 2016
-
-7.70%(-39.1%)
Mar 2016
-
-12.65%(-123.4%)
Dec 2015
-
54.06%(+34.1%)
Sep 2015
49.10%(-31.9%)
40.32%(+93.4%)
Jun 2015
-
20.85%(-58.4%)
Mar 2015
-
50.12%(-7.5%)
Dec 2014
-
54.21%(-128.4%)
Sep 2014
72.14%(+140.2%)
-191.20%(-20.6%)
Mar 2014
-
-240.88%(-59.9%)
Dec 2013
-
-601.34%(+82.6%)
Sep 2013
30.03%(-41.5%)
-329.36%(+31.3%)
Jun 2013
-
-250.94%(-19.9%)
Mar 2013
-
-313.46%(-497.7%)
Dec 2012
-
78.81%(-136.1%)
Sep 2012
51.31%(-7.8%)
-218.08%(+58.3%)
Jun 2012
-
-137.73%(-256.8%)
Mar 2012
-
87.82%(-120.6%)
Dec 2011
-
-426.32%
Sep 2011
55.66%(+60.3%)
-
Sep 2010
34.72%
-

FAQ

  • What is Enanta Pharmaceuticals annual net profit margin?
  • What is the all time high annual net margin for Enanta Pharmaceuticals?
  • What is Enanta Pharmaceuticals annual net margin year-on-year change?
  • What is Enanta Pharmaceuticals quarterly net profit margin?
  • What is the all time high quarterly net margin for Enanta Pharmaceuticals?
  • What is Enanta Pharmaceuticals quarterly net margin year-on-year change?

What is Enanta Pharmaceuticals annual net profit margin?

The current annual net margin of ENTA is -171.58%

What is the all time high annual net margin for Enanta Pharmaceuticals?

Enanta Pharmaceuticals all-time high annual net profit margin is 72.14%

What is Enanta Pharmaceuticals annual net margin year-on-year change?

Over the past year, ENTA annual net profit margin has changed by -2.63% (-1.56%)

What is Enanta Pharmaceuticals quarterly net profit margin?

The current quarterly net margin of ENTA is -197.32%

What is the all time high quarterly net margin for Enanta Pharmaceuticals?

Enanta Pharmaceuticals all-time high quarterly net profit margin is 87.82%

What is Enanta Pharmaceuticals quarterly net margin year-on-year change?

Over the past year, ENTA quarterly net profit margin has changed by -48.86% (-32.91%)